Dr. Nabeel Aslam, MD

Dr. Aslam practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Aslam's NPI, 1174579148, was assigned on May 25, 2006. Dr. Aslam graduated from King Edward Medical University in 1993. Dr. Aslam holds Florida license ME107682.

Dr. Aslam's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Aslam's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Aslam to 1 more dialysis center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aslam practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Aslam's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Aslam is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Aslam's licenses on file in 4 states: Florida, Michigan, Pennsylvania and Connecticut.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia, kidney cysts and kidney disease among the conditions Dr. Aslam treats.

CMS data shows 504 Medicare services from Dr. Aslam across 9 procedure codes in 2024, for 262 Medicare patients. Medicare paid $61,440 for them.

CMS counts 262 Medicare patients who saw Dr. Aslam in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 3.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aslam's median patient age at 63, with 50% women.

In 2024, Dr. Aslam wrote 380 Medicare Part D claims for 68 patients. 91% of them were for generic drugs. CMS names the drug for 223 of them, across 13 drugs with 11 or more claims each, at $15,897 in total drug cost. In 2023, CMS named 245 claims across 13 drugs.

Dr. Aslam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aslam as offering telehealth.

Dmand AI links 49 papers to Dr. Aslam, published from 2006 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Peritoneal Dialysis, Kidney Failure, Chronic and Rituximab. Dr. Aslam has published most often in Clin J Am Soc Nephrol. Dr. Aslam's most frequent co-authors are Lyle Wesley Baker, MD, Christopher Trautman, MD and Hani Wadei, MD.

Dmand AI links Dr. Aslam to 1 clinical trial. Conditions studied include Glomerulonephritis, Membranous and Glomerulonephritis.

CMS Open Payments shows 24 general payments to Dr. Aslam from 7 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Travere Therapeutics, Inc. paid the most, $3,892.

Dmand AI lists 1 award for Dr. Aslam.

Dr. Aslam graduated from King Edward Medical University in 1993. Dr. Aslam is a member of ASN.

Dr. Aslam is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. POS plans come from the most carriers, 6. Check the plan with the practice before a visit.